S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
66,000% upside on tiny biotech? (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Global shares mostly rise despite worries about US debt talks
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
66,000% upside on tiny biotech? (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Global shares mostly rise despite worries about US debt talks
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
66,000% upside on tiny biotech? (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Global shares mostly rise despite worries about US debt talks
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
66,000% upside on tiny biotech? (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Global shares mostly rise despite worries about US debt talks
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
NYSE:CL

Colgate-Palmolive (CL) Price Target & Analyst Ratings

$79.93
+0.24 (+0.30%)
(As of 05/19/2023 08:48 PM ET)
Compare
Today's Range
$79.37
$80.04
50-Day Range
$71.50
$81.98
52-Week Range
$67.84
$83.81
Volume
3.76 million shs
Average Volume
4.71 million shs
Market Capitalization
$66.31 billion
P/E Ratio
41.63
Dividend Yield
2.40%
Price Target
$84.75

Colgate-Palmolive Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 10 Analyst Ratings

Consensus Analyst Price Target

$84.75
6.03% Upside
High Prediction$92.00
Average Prediction$84.75
Low Prediction$77.00
TypeCurrent
5/22/22 to 5/22/23
1 Month Ago
4/22/22 to 4/22/23
3 Months Ago
2/21/22 to 2/21/23
1 Year Ago
5/22/21 to 5/22/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
3 Buy rating(s)
Hold
3 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
12 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$84.75$81.70$82.09$85.80
Predicted Upside6.03% Upside11.49% Upside11.45% Upside8.40% Upside
Get Colgate-Palmolive Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CL and its competitors with MarketBeat's FREE daily newsletter.


CL Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Colgate-Palmolive Stock vs. The Competition

TypeColgate-PalmoliveConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.70
2.45
2.48
Consensus RatingModerate BuyHoldHold
Predicted Upside6.03% Upside103,553.49% Upside173.86% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/1/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$80.00 ➝ $88.00+9.44%
5/1/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$82.00 ➝ $83.00+3.98%
5/1/2023Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$85.00 ➝ $91.00+14.04%
5/1/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$80.00 ➝ $85.00+6.52%
5/1/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$76.00 ➝ $81.00+1.50%
5/1/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$88.00 ➝ $92.00+15.29%
3/29/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$84.00 ➝ $86.00+15.44%
1/31/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$80.00 ➝ $77.00+5.65%
1/30/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeEqual Weight ➝ Overweight$82.00+14.54%
1/13/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$81.00 ➝ $86.00+11.92%
11/21/2022Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform
10/18/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$88.00 ➝ $85.00+17.83%
10/10/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$91.00 ➝ $81.00+17.32%
(Data available from 5/22/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CL Price Target - Frequently Asked Questions

What is Colgate-Palmolive's consensus rating and price target?

According to the issued ratings of 10 analysts in the last year, the consensus rating for Colgate-Palmolive stock is Moderate Buy based on the current 3 hold ratings and 7 buy ratings for CL. The average twelve-month price prediction for Colgate-Palmolive is $84.75 with a high price target of $92.00 and a low price target of $77.00. Learn more on CL's analyst rating history.

Do Wall Street analysts like Colgate-Palmolive more than its competitors?

Analysts like Colgate-Palmolive more than other Consumer Staples companies. The consensus rating for Colgate-Palmolive is Moderate Buy while the average consensus rating for consumer staples companies is Hold. Learn more on how CL compares to other companies.

Does Colgate-Palmolive's stock price have much upside?

According to analysts, Colgate-Palmolive's stock has a predicted upside of 12.89% based on their 12-month price targets.

What analysts cover Colgate-Palmolive?

Stock Ratings Reports and Tools

This page (NYSE:CL) was last updated on 5/22/2023 by MarketBeat.com Staff

My Account -